NU674 · Unit 9

NU674 Unit 9 focused follow-up note example

PMHNP Diagnosis and Management Across the Lifespan Clinical I Purdue University Global Free custom sample in 24 to 48h

Nightmares down from [six] nights in seven to [four], one dizzy spell on standing, and a return to the fire station's light-duty roster: that is the interval a composite [37]-year-old wildland firefighter reports [fourteen] days after starting [prazosin]. Recorded on a single page for NU674 Unit 9, that interval is measured against the intake baseline, and the focused follow-up note keeps the plan deliberately unchanged.

What this page holds

Interval change against baseline, side effects checked individually and an unchanged plan with its reasons make up this NU674 Unit 9 note on a composite firefighter. Searches like "nu 674 unit 9 assignment example", "nu674 unit 9 sample" and "nu674 unit 9 example" land here.

What a finished NU674 Unit 9 focused follow-up note looks like

One page in SOAP order. Subjective opens with the interval since intake: nightmare count from the sleep log he keeps, [four] nights in the last seven against [six] at baseline, and the light-duty return. Side effects are listed as questions and answers: dizziness on standing, yes, once, on the second night; morning grogginess, no; nasal congestion, no; headache, no. Objective records blood pressure seated and standing, [118/76] and [110/72], and a PCL-5 total of [49] against [58] at intake. A brief mental status examination, [five] lines, notes a brighter affect and no change in thought content, with the safety questions asked again and answered. Assessment names PTSD, early partial improvement. Plan continues [prazosin] at [2 mg] nightly, with the reason stated, and books a return in [fourteen] days.

How a NU674 Unit 9 example is structured

Everything in the note is written as change from a reference point, and it is named: the intake evaluation [fourteen] days earlier. Subjective material leads with the target symptom the medication was started for, nightmares, counted from his own log rather than recalled as better. Side effects are recorded as asked questions, each with its answer, so a covering clinician can tell that orthostatic dizziness was specifically explored, the effect most expected early with this drug. Objective data pair the standing blood pressure with the seated reading, since orthostasis cannot be judged from one number. The brief mental status examination is limited to domains that could have changed. Assessment states direction and degree, early and partial. The plan explains why nothing changes today: improvement is underway, the dizziness was single and mild, and a dose increase can wait.

A baseline named at the top

The note opens by citing the intake evaluation and its date. Every later comparison, from nightmare count to checklist score, refers back to that document, so a reader never wonders what better means. Brief notes depend on that anchor more than long ones do.

Nightmares counted from his log

Frequency comes from the sleep log he keeps at home, reported as nights in the last seven. A count lets the next visit measure change; an impression of fewer bad dreams would not. The log itself stays with him; only the tally enters the note.

Standing pressure beside seated

Two blood pressure readings sit together in the objective section, with the difference stated. His drop is small, which supports continuing the dose despite the one dizzy spell he reported on the second night. The note does not call it orthostatic hypotension, since the numbers do not meet that definition.

A five-line mental status examination

Only domains that could shift in [fourteen] days are recorded: affect, speech, thought content and safety. Appearance earns a line only because he arrived in uniform for the first time. The full examination stays in the evaluation, and the brevity here signals a follow-up rather than an omission.

Holding steady, with reasons

Continuing the same dose is a decision, and the note records it as one: improvement underway, a single mild side effect, and a plan to reconsider the dose at the next visit if nightmares plateau.

Where marks go in NU674 Unit 9

A stranger reading a follow-up note should be able to tell what changed since the last visit, and the commonest weakness is a note that records how the patient is doing without saying compared to what. Improvement described as doing better, or sleeping better, with no count or score, earns little. Side effects summarized as none draw a comment unless the individual effects explored are listed, and with an alpha-blocker a missing standing blood pressure is noticed. A brief mental status examination is expected too; skipping it because the evaluation already has one leaves the visit without an objective psychiatric finding. An unchanged plan with no reason reads as inattention rather than judgment. Small points go for a note running to three pages, safety omitted at follow-up, and no date for the return visit.

Get a NU674 Unit 9 example written to your instructions

Follow-up note formats run from SOAP to DAP to a site's own template, so name the one NU674 expects for Unit 9 and share the rubric with an anonymized summary of the visit. The composite note that comes back, free the first time and within 24-48h, measures interval change against a named baseline and gives the plan its reasons.

NU674 Unit 9 questions, answered

What belongs in a focused follow-up note that is not in the evaluation?

Change. The note assumes the evaluation exists and records what is different since then: target symptoms, side effects explored, adherence, safety, a brief examination, and whether the plan moves. Repeating the history wastes the reader's time. A short line citing the evaluation and its date is enough to anchor every comparison the note makes.

What is the PCL-5?

The PTSD Checklist for DSM-5, developed at the National Center for PTSD by Weathers and colleagues, is a 20-item self-report measure scored from 0 to 80. It tracks symptom change well across visits. It is not a diagnosis on its own, and the note reports the score beside the clinical picture rather than letting a number stand in for the assessment.

Why record a decision not to change anything?

Because an unchanged plan is still a clinical judgment, and a reader needs its reasons as much as the reasons for a dose change. Without them, continuing the same dose can look like a missed opportunity or an oversight. One sentence naming the improvement seen, the side effect weighed and the condition that would prompt a change is usually enough.